Diadema Partners »

Entera Bio shares owned by Diadema Partners

Quarter-by-quarter ownership of Entera Bio (ENTX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Entera Bio

Tip: Access up to 7 years of quarterly data

All positions including Entera Bio held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entera Bio by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $26k 23k 1.11

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Entera Bio

Knoll Capital Management
Renaissance Technologies
Parkman Healthcare Partners
Citadel Advisors
Seven Fleet Capital Management
Marshall Wace
Northern Trust
XTX Topco
Schonfeld Strategic Advisors
Signature Estate and Investment Advisors
HighTower Advisors
Jane Street
Diadema Partners
Geode Capital Management
Hrt Financial

View all funds holding Entera Bio